The present invention relates to 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones
of formula I:
##STR1##
or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable
salt forms thereof, wherein A is selected from NCN, NCONH2, and NOR9.
The present invention relates to compounds which are useful as inhibitors of HIV
reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising
the same, and methods of using the same for treating viral infection or as an assay
standard or reagent.
